Big Sioux Wealth Management’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11
Closed -$12 – 234
2026
Q2
$12 Hold
11
– – ﹤0.01% 417
2026
Q1
$19 Hold
11
– – ﹤0.01% 414
2025
Q4
$19 Buy
+11
New +$24 ﹤0.01% 413

Other funds holding INO

Big Sioux Wealth Management's INO Position: Q3 2026 in Review

Big Sioux Wealth Management sold out of Inovio Pharmaceuticals (INO) in Q3 2026, closing a stake of 11 shares — an estimated $12 sold.

Big Sioux Wealth Management first reported a position in INO in Q4 2025 and held it in 3 quarters. The position peaked at $19 in Q1 2026. 112 funds tracked by Wall St. Rank hold INO as of Q3 2026.

  • Big Sioux Wealth Management reported no remaining Inovio Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Big Sioux Wealth Management sold 11 Inovio Pharmaceuticals shares in Q3 2026, an estimated $12.
  • Big Sioux Wealth Management first reported a position in Inovio Pharmaceuticals in Q4 2025 and held it in 3 quarters.
  • Big Sioux Wealth Management's Inovio Pharmaceuticals position peaked at $19 in Q1 2026.
  • 112 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2026.

Based on Big Sioux Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.